This information was published on 2024-12-04T15:15:25 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2502439 (IR 1825260) |
| (220) |
07 May 2024
|
| (300) |
US, 09 Nov 2023, 98262764
US, 09 Nov 2023, 98262771 US, 09 Nov 2023, 98262773 US, 09 Nov 2023, 98262767 US, 09 Nov 2023, 98262768 |
| (511) (510) |
Class 1
Chemical substances, chemical materials and chemical preparations; active pharmaceutical ingredients, namely, antibodies, proteins and small molecules for use in the manufacture of pharmaceuticals, biopharmaceuticals, vaccines, and finished drug products; antibodies for use in the manufacture of active ingredients of pharmaceuticals and vaccines. Class 5 Pharmaceutical preparations; diagnostic preparations for medical purposes; monoclonal antibodies; chemical, biological and biochemical reagents for medical or veterinary purposes; diagnostic kits consisting primarily of monoclonal antibodies for use in disease testing; diagnostic test kits comprised of medical diagnostic reagents and assays that test for the presence of antigens, pathogens, biomarkers for diseases, or biomarkers for predicting patients' response to therapeutic agents. Class 10 Medical devices. Class 42 Research, development and consultation related thereto in the medical, pharmaceutical research and biotechnology fields; pharmaceutical research and development of pharmaceutical preparations; research and development services in the fields of human and animal pharmaceutical and biotechnology drug development and manufacture; laboratory research services in connection with developing new medicinal products; scientific research, development and consultation services in the fields of immunology, antibodies, vaccines, medicine, biotherapeutics, and therapeutics. Class 44 Medical services. |
| (540) | MIRADOR |
| (550) | Word |
| (730) |
Mirador Therapeutics, Inc.
|
Find out more about publications on the About page.